Industry News | tctmd.com

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Industry News

Boston Scientific Introduces First iPad® App for Physicians to Educate Patients About Cardiovascular Diseases and Treatments

October 27, 2011

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Industry News

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer

November 10, 2011

News Industry News

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

November 07, 2011

News Industry News

Outstanding interim results of STENTYS international clinical study of 600 heart attack patients

November 07, 2011

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Industry News

CUMC Expert Raises Concerns about Heart Disease Trends

November 09, 2011

Subscribe to Industry News

Advertisement

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Boston Scientific Introduces First iPad® App for Physicians to Educate Patients About Cardiovascular Diseases and Treatments

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

Outstanding interim results of STENTYS international clinical study of 600 heart attack patients

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

CUMC Expert Raises Concerns about Heart Disease Trends

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content